MFBIX Fees and Costs — Mesirow Enhanced Core Plus Fund, Institutional Shares
Data updated: 2025-02-28
The net expense ratio is 0.54%: a 0.37% management fee plus 1.79% other expenses, less a 1.62% fee waiver. This share class carries a redemption fee of 1.00%. Portfolio turnover was 231%.
MFBIX Fees and Expenses
Annual operating expenses and sales charges of MFBIX. Prospectus, as of January 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.37% |
| 12b-1 fee | 0.00% |
| Other expenses | 1.79% |
| Gross expense ratio | 2.16% |
| Fee waiver | −1.62% |
| Net expense ratio | 0.54% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | 1.00% |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | Yes |
MFBIX Costs Over Time
On $10,000 invested in MFBIX, assuming 5% a year before costs, total costs come to $341 over 5 years, cutting the return by 0.57% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.54%) | $57 | $178 | $310 |
| Lost growth on money paid in costs | $0 | $9 | $31 |
| Total costs | $57 | $187 | $341 |
| Value after costs | $10,443 | $11,390 | $12,422 |
| Impact on return, per year | 0.57% | 0.57% | 0.57% |
MFBIX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending September 30, 2024.
- Explicit cost rate (commissions ÷ average net assets): —
- Total broker commissions: —
- Bought from dealers (principal trades, not a cost): $78.7M
- Portfolio turnover (prospectus): 231%
- Securities lending: none during the year
MFBIX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| BMO CAPITAL | $12.8M | 22.64% |
| CHASE SECURITIES, INC. | $8.1M | 14.30% |
| BARCLAYS CAPITAL INC - NY | $7.2M | 12.64% |
| GOLDMAN, SACHS & CO. | $6.8M | 11.94% |
| US BANCORP INVESTMENTS INC. | $6.2M | 10.93% |
| CITADEL | $4.1M | 7.25% |
| MORGAN STANLEY & CO, INC | $3.6M | 6.41% |
| MONTGOMERY/BANK OF AMERICA | $3.4M | 6.04% |
| CITIGROUP GLOBAL MARKETS | $2.4M | 4.27% |
| RBC DAIN RAUSCHER INC. | $2.0M | 3.58% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.